Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
Charles R. Penn, Sherif R. Zaki(Centers for Disease Control and Prevention), Michael W. Shaw(Centers for Disease Control and Prevention), Timothy M. Uyeki(Cambodia National Malaria Center), Scott A. Harper, Tawee Chotpitayasunondh(Queen Sirikit National Institute of Child Health), Frederick G. Hayden(University of Virginia Health System), David S.C. Hui(Chinese University of Hong Kong), Matthew L. Lim, Nahoko Shindo(World Health Organization), Zhancheng Gao(Shanxi Medical University), Edgar Bautista
Cited by 1,068
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009
|New England Journal of Medicine|2009|1.7k
COVID-19: what is next for public health?
|The Lancet|2020|1.2k